We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product

News   May 02, 2008

 
EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product
 
 
 

RELATED ARTICLES

Patent Issued for Osteoarthritis Gene Therapy Product

News

A potentially disease-modifying therapy for osteoarthritis has reached a key milestone now that a U.S. patent has been issued for FX201, a gene-therapy product candidate based on work led by Baylor College of Medicine researchers.

READ MORE

Stage Set for Uncovering Multiple Autoimmune Drug Targets

News

The identification of molecular signatures that reflect the pathology of lupus and arthritis provide new insights into tissue damage, and set the stage for uncovering potential drug target candidates.

READ MORE

Schizophrenia: Hippocampus Drastically Shrinks in Adolescents With Psychotic Symptoms

News

Schizophrenia may be related to genetic abnormalities of chromosome 22, known as 22q11 deletion syndrome. However, not everyone who has the syndrome necessarily develops psychotic symptoms. So, what triggers the illness? An 18-year-long study provides some answers.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE